Additionally, in breast cancer, IFN signatures are associated with metastatic disease in specific tumor phenotypes: ESR1+/ERBB2 − tumor metastasis is associated with IFN expression whereas ERBB2 + is not43. Here, ERBB2 is linked to breast cancer.